Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
NVOS
Upturn stock rating

Novo Integrated Sciences Inc (NVOS)

Upturn stock rating
$0.01
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

10/24/2025: NVOS (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -89.18%
Avg. Invested days 22
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulation Last Close 10/24/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 0.08M USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) -
Beta 1
52 Weeks Range 0.00 - 0.80
Updated Date 06/29/2025
52 Weeks Range 0.00 - 0.80
Updated Date 06/29/2025
Dividends yield (FY) -
Basic EPS (TTM) -1.33

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -121.61%
Operating Margin (TTM) -30.39%

Management Effectiveness

Return on Assets (TTM) -15.35%
Return on Equity (TTM) -82.47%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 3040806
Price to Sales(TTM) 0.01
Enterprise Value 3040806
Price to Sales(TTM) 0.01
Enterprise Value to Revenue 0.23
Enterprise Value to EBITDA -1.58
Shares Outstanding 19730200
Shares Floating 18430616
Shares Outstanding 19730200
Shares Floating 18430616
Percent Insiders 6.59
Percent Institutions -

ai summary icon Upturn AI SWOT

Novo Integrated Sciences Inc

stock logo

Company Overview

overview logo History and Background

Novo Integrated Sciences Inc. was founded to provide integrated healthcare solutions, focusing on minimally invasive diagnostics and treatment protocols. Over time, it has evolved through acquisitions and strategic partnerships to expand its service offerings and geographic reach.

business area logo Core Business Areas

  • Medical Clinics: Operates and manages medical clinics that provide various healthcare services, including neuromusculoskeletal care, rehabilitation, and other specialized treatments.
  • Rehabilitation Services: Offers rehabilitation programs and services to help patients recover from injuries, illnesses, and surgeries.
  • Technology Development: Develops and commercializes medical technologies and devices focused on minimally invasive diagnostics and therapies.

leadership logo Leadership and Structure

The company is led by a management team with expertise in healthcare operations, medical technology, and finance. The organizational structure is typically hierarchical, with departments responsible for operations, finance, marketing, and technology development.

Top Products and Market Share

overview logo Key Offerings

  • Neuromusculoskeletal Care: Provides diagnostic and treatment services for neuromusculoskeletal conditions. No concrete standalone market share data available. Competitors include traditional chiropractic practices and larger healthcare networks offering similar services.
  • Rehabilitation Programs: Offers customized rehabilitation programs for patients recovering from injuries or surgeries. Revenue and market share data are not publicly available. Competitors include physical therapy clinics and rehabilitation centers.

Market Dynamics

industry overview logo Industry Overview

The healthcare industry is characterized by increasing demand for integrated and minimally invasive treatment options, driven by an aging population and growing awareness of preventive care.

Positioning

Novo Integrated Sciences Inc. aims to position itself as a provider of comprehensive and integrated healthcare solutions, focusing on minimally invasive techniques and personalized care.

Total Addressable Market (TAM)

The total addressable market (TAM) for integrated healthcare services is estimated to be in the billions of dollars. Novo Integrated Sciences Inc. is positioned to capture a share of this TAM through its network of clinics and technology offerings.

Upturn SWOT Analysis

Strengths

  • Integrated Healthcare Model
  • Focus on Minimally Invasive Treatments
  • Experienced Management Team
  • Proprietary Technology

Weaknesses

  • Limited Brand Recognition
  • Small Market Share Compared to Larger Competitors
  • Dependence on Key Personnel
  • Financial Volatility

Opportunities

  • Expansion of Clinic Network
  • Strategic Partnerships with Healthcare Providers
  • Development of New Medical Technologies
  • Increasing Demand for Integrated Healthcare

Threats

  • Regulatory Changes
  • Increased Competition
  • Economic Downturn
  • Changes in Healthcare Reimbursement Policies

Competitors and Market Share

competitor logo Key Competitors

  • US stock market lacks direct competitors with a similar profile. (No Listed Competitor)
  • Large Healthcare Networks (N/A)
  • National Rehabilitation Centers (N/A)

Competitive Landscape

Novo Integrated Sciences Inc. faces competition from larger healthcare networks and specialized clinics. Its advantages include its integrated model and focus on minimally invasive treatments. Its disadvantages include limited brand recognition and smaller market share.

Growth Trajectory and Initiatives

Historical Growth: Historical growth has been driven by acquisitions and expansion of clinic networks. Specific growth percentages cannot be provided without financial data.

Future Projections: Future growth is projected to be driven by increased demand for integrated healthcare solutions and the development of new medical technologies. Analyst estimates vary.

Recent Initiatives: Recent initiatives include expanding clinic locations and developing new technology platforms.

Summary

Novo Integrated Sciences Inc. is a small player in the healthcare market with a focus on integrated and minimally invasive treatments. While it has growth potential through its expansion plans and technological advancements, it faces challenges including limited brand recognition and competition from larger healthcare networks. The company's future success depends on its ability to execute its growth strategy and capitalize on the increasing demand for integrated healthcare solutions. The high volatility of the company's financials makes it a speculative investment.

Similar Stocks

Sources and Disclaimers

Data Sources:

  • Company Website
  • SEC Filings (limited data available)
  • Industry Reports
  • Analyst Reports (limited data available)

Disclaimers:

The data provided is based on limited publicly available information and should not be considered financial advice. Investment decisions should be made after conducting thorough research and consulting with a financial advisor.

Upturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Novo Integrated Sciences Inc

Exchange NASDAQ
Headquaters Bellevue, WA, United States
IPO Launch date 2017-09-22
CEO -
Sector Healthcare
Industry Medical Care Facilities
Full time employees 115
Full time employees 115

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates in two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health programs, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning programs, including event and game coverage, and private personal training services through clinics. It also provides assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across pediatric, adult, and geriatric populations. In addition, the company offers eldercare physiotherapy services through long-term care homes, retirement homes, community-based home care physiotherapy, community-based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement homes and community, and long-term care sectors. Further, it provides medical technology platforms, such as Novo Connect, telemedicine/telehealth, and remote patient monitoring; and develops and distributes personalized health and wellness product solutions. The company was formerly known as Turbine Truck Engines, Inc. and changed its name to Nova Integrated Sciences, Inc. in July 2017. The company is headquartered in Bellevue, Washington.